oncothyreon inc (ONTY:NASDAQ GS)
Diana F. Hausman M.D.
Chief Medical Officer, Oncothyreon Inc
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2013
Dr. Diana Hausman, M.D. has been the Chief Medical Officer at Oncothyreon Inc. since January 5, 2012 and served as its Vice President of Clinical Development from August 2009 to January 2012. Dr. Hausman is responsible for planning and implementing the clinical development program for Oncothyreon's pipeline of oncology product candidates. She is an experienced oncologist with an extensive background in drug development. Dr. Hausman joined Oncothyreon from Zymogenetics, ...
2601 Fourth AvenuePhone: 206-801-2100
Seattle, Washington 98121
Board Members Memberships*There is no Board Members Memberships data available.
University of Washington
The University of Pennsylvania
|There is no Competitor Compensation data available.|